Abraham; Judith A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Abraham; Judith A..The latest application filed is for "use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancers".

Company Profile

0.12.8

Abraham; Judith A. - San Jose CA
Abraham; Judith A. - Sunnyvale CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers Grant 7,476,506 - Schleyer , et al. January 13, 2	2009-01-13
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers App 20080008711 - Schleyer; Siew C. ; et al.	2008-01-10
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers App 20070148691 - Schleyer; Siew C. ; et al.	2007-06-28
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers Grant 7,198,899 - Schleyer , et al. April 3, 2	2007-04-03
Recombinant fibroblast growth factor analogs Grant 7,186,526 - Fiddes , et al. March 6, 2	2007-03-06
Recombinant fibroblast growth factor analogs App 20050227329 - Fiddes, John C. ; et al.	2005-10-13
Vascular endothelial growth factor dimers App 20050119165 - Jue, Rodney Alan ; et al.	2005-06-02
Vascular endothelial growth factor variants Grant 6,887,848 - Pollitt , et al. May 3, 2	2005-05-03
Vascular endothelial growth factor dimers App 20040241800 - Jue, Rodney Alan ; et al.	2004-12-02
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers App 20040005622 - Schleyer, Siew C. ; et al.	2004-01-08
Vascular endothelial growth factor variants App 20030096754 - Pollitt, N. Stephen ; et al.	2003-05-22
Recombinant fibroblast growth factors App 20030040042 - Fiddes, John C. ; et al.	2003-02-27
Vascular endothelial growth factor variants Grant 6,475,796 - Pollitt , et al. November 5, 2	2002-11-05
Human basic fibroblast growth factor analog Grant 6,294,359 - Fiddes , et al. September 25, 2	2001-09-25
Heparin binding mitogen with homology to epidermal growth factor (EGF) Grant 5,811,393 - Klagsbrun , et al. September 22, 1	1998-09-22
Recombinant human basic fibroblast growth factor Grant 5,604,293 - Fiddes , et al. February 18, 1	1997-02-18
Methods of producing recombinant fibroblast growth factors Grant 5,514,566 - Fiddes , et al. May 7, 1	1996-05-07
DNA encoding human recombinant basic fibroblast growth factor Grant 5,439,818 - Fiddes , et al. August 8, 1	1995-08-08
DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF.sub.120 and hVEGF.sub.121 Grant 5,219,739 - Tischer , et al. June 15, 1	1993-06-15
Production of vascular endothelial cell growth factor Grant 5,194,596 - Tischer , et al. March 16, 1	1993-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.